Now available Morphabond ER is the only single agent

MORPHABOND ER is the only single-agent, abuse-deterrent, ER morphine with SentryBond Technology1,2

Abuse of MORPHABOND ER is still possible by intranasal, intravenous, and oral routes

  Bioequivalent to MS Contin®

  Retains its extended-release properties even if manipulated and/or chemically extracted

  Expected to deter abuse by both
intranasal and injection administration

Eligible commercially insured patients may pay as little as $10 a month*


*Eligibility Criteria and Terms and Conditions apply.



Daiichi Sankyo is committed to responsible use of prescription pain medications